NEW YORK – Pacific Biosciences on Wednesday said it will work with molecular diagnostics firm Invitae to develop a production-scale, high-throughput whole-genome sequencing (WGS) platform for clinical use.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.